The Hematology Podcast
1) Same Same but Different – Rare but not so rare?
Send us a text Gaucher disease is a rare lysosomal storage disorder that presents with varying prevalence and management approaches across Nordic countries. Despite geographical proximity, these count...Show More
2) Vaccinations after Hematopoietic Stem Cell Transplant
Send us a text Hematopoietic stem cell transplantation is a crucial part of the treatment of many hematological malignancies. One important effect is alteration of the immune system. To overcome this,...Show More
3) Transforming Hematology: The Power of AI
Send us a text The integration of artificial intelligence (AI) into routine clinical practice is poised to revolutionize the diagnosis and treatment of hematologic diseases. AI-based models are alread...Show More
4) ITP - Beyond platelet counts
Send us a text Immune Thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count, which can lead to increased bleeding and bruising. In this episode, we will discuss the pa...Show More
5) High risk Multiple Myeloma - an update
Send us a text A new genomic definition of high-risk multiple myeloma (HR-MM) has been recently proposed by IMS/IMWG. The associated peer-reviewed publication is planned to be released in Spring 2025....Show More
6) TMA or Thrombotic microangiopathy - from Symptoms to Treatment
In this episode of The Hematology Podcast, we will delve into the complex world of thrombotic microangiopathy, or TMA. This condition encompasses a group of disorders characterized by small blood clot...Show More
7) Decoding Multiple Myeloma genetic profile: The Power of Liquid Biopsy-Derived DNA
In this episode, we dive into the fascinating world of liquid biopsy-derived DNA as a revolutionary tool for comprehensive mutation profiling in multiple myeloma. This innovative approach offers a non...Show More
8) Transfusion Dependent Thalassemia - the Severe Spectrum
In this episode, we focus on a severe form of Thalassemia known as Thalassemia major. In a previous episode, we discussed Thalassemia minor and intermedia with Professor Dr. Bart Biemond from Amsterda...Show More
9) AML - from basics to future prospectives
Acute myeloid leukemia (AML) is a hematopoietic stem cell-derived myeloid malignancy characterized by manifold genetic aberrations and poor overall survival. Standard treatment for newly diagnosed fit...Show More
10) Smoldering Multiple Myeloma – to treat or not to treat?
Smoldering multiple myeloma (SMM) is an intermediate condition that lies between Monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma along the spectrum of clonal plas...Show More